These increased levels often occur during exacerbations of the diseases and correlate with biomarkers of disease activity, suggesting that the expression of IL37 corresponds to the disease activity of RA, ankylosing spondylitis (AS), Graves’ disease (GD), and SLE [25,26,27,28]. Here, IL37 is linked to Graves disease.